These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6286189)

  • 41. Stimulation of DNA synthesis and mitosis of hepatocytes in primary cultures of neonatal rat liver by arachidonic acid and prostaglandins.
    Andreis PG; Whitfield JF; Armato U
    Exp Cell Res; 1981 Aug; 134(2):265-72. PubMed ID: 6791948
    [No Abstract]   [Full Text] [Related]  

  • 42. Cyclic AMP and prostaglandins in periodontal disease.
    ElAttar TM; Lin HS
    Adv Prostaglandin Thromboxane Res; 1980; 8():1739-40. PubMed ID: 6246791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of prostaglandins on in vitro electrolyte metabolism in human spongiosa].
    Keck E; Schärtl A; Zeidler H; Menge M
    Z Rheumatol; 1984; 43(5):258-64. PubMed ID: 6596815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discharge characteristics of receptors with fine afferents from normal and inflamed joints: influence of analgesics and prostaglandins.
    Schaible HG; Schmidt RF
    Agents Actions Suppl; 1986; 19():99-117. PubMed ID: 3463187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin E2 and prostacyclin elevate cyclic AMP levels in elicited populations of mouse peritoneal macrophages.
    Bonney RJ; Burger S; Davies P; Kuehl FA; Humes JL
    Adv Prostaglandin Thromboxane Res; 1980; 8():1691-3. PubMed ID: 6246787
    [No Abstract]   [Full Text] [Related]  

  • 46. Antagonistic effects of N-ethylmaleimide on platelets treated with agents that are known to increase levels of cyclic AMP.
    Wörner P; Patscheke H
    Thromb Res; 1981 Jan 1-15; 21(1-2):201-6. PubMed ID: 6262945
    [No Abstract]   [Full Text] [Related]  

  • 47. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 48. Prostaglandins, macrophages, and immunity.
    Stenson WF; Parker CW
    J Immunol; 1980 Jul; 125(1):1-5. PubMed ID: 6991596
    [No Abstract]   [Full Text] [Related]  

  • 49. Inductive effects of prostaglandins on alkaline phosphatase in osteoblastic cells, clone MC3T3-E1.
    Hakeda Y; Nakatani Y; Hiramatsu M; Kurihara N; Tsunoi M; Ikeda E; Kumegawa M
    J Biochem; 1985 Jan; 97(1):97-104. PubMed ID: 2581942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rabbit and rat renal papillary collecting tubule cells in culture: the interactions of arginine vasopressin, prostaglandins, and cyclic AMP.
    Pugliese F; Sato M; Williams S; Aikawa M; Hassid A; Dunn M
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():517-23. PubMed ID: 6303076
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of prostaglandins, phosphodiesterase inhibitors, and cyclic AMP on ovulation of brook trout (Salvelinus fontinalis) oocytes.
    Goetz FW; Smith DC; Krickl SP
    Gen Comp Endocrinol; 1982 Oct; 48(2):154-60. PubMed ID: 6292040
    [No Abstract]   [Full Text] [Related]  

  • 52. Prostaglandin I2 and E1 and red cell deformability in raynaud's phenomenon and systemic sclerosis.
    Gaylarde PM
    Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1608-9. PubMed ID: 6796187
    [No Abstract]   [Full Text] [Related]  

  • 53. The enhancing effect of multiple sclerosis brain homogenates on the active E rosette forming lymphocytes.
    Offner H; Rastogi SC; Konat G; Calusen J
    J Neurol; 1978 Aug; 218(4):245-51. PubMed ID: 81273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Labelled-calcium release from rat mandibles exposed to prostaglandins in vitro.
    Hirata H; Dohi T; Terada H; Tanaka S; Okamoto H; Tsujimoto A
    Arch Oral Biol; 1983; 28(10):963-5. PubMed ID: 6580854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphocyte adherence in multiple sclerosis: effect of aspirin.
    Dore-Duffy P; Zurier RB
    J Clin Invest; 1979 Jan; 63(1):154-7. PubMed ID: 762244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prostaglandin and related substances].
    Morita I
    Nihon Rinsho; 1986 Jan; 44(1):141-6. PubMed ID: 3514988
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of prostaglandin in the depressed cell-mediated immune response in rheumatoid arthritis.
    Wolinsky SI; Goodwin JS; Messner RP; Williams RC
    Clin Immunol Immunopathol; 1980 Sep; 17(1):31-7. PubMed ID: 6447561
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of inflammation mediators and antirheumatic drugs on the production of superoxide anion (O2-) by polymorphonuclear cells in normals and rheumatoid arthritis].
    Pellegrini R; Lalumera M; Berti C; Morozzi G; Marcolongo R
    Boll Soc Ital Biol Sper; 1982 Apr; 58(7):392-6. PubMed ID: 6282292
    [No Abstract]   [Full Text] [Related]  

  • 59. Differences in blood pressure lowering effects in PGs following indirect and direct blood pressure measurements.
    Hedley LR; Van Antwerp DR; Strosberg AM
    Proc West Pharmacol Soc; 1984; 27():323-7. PubMed ID: 6593737
    [No Abstract]   [Full Text] [Related]  

  • 60. Lymphocyte adherence in multiple sclerosis: role of the cytoskeleton and prostaglandin E.
    Dore-Duffy P; Zurier RB
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):277-87. PubMed ID: 3464022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.